These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 10807052)

  • 1. T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency.
    Smogorzewska EM; Brooks J; Annett G; Kapoor N; Crooks GM; Kohn DB; Parkman R; Weinberg KI
    Arch Immunol Ther Exp (Warsz); 2000; 48(2):111-8. PubMed ID: 10807052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.
    Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Brown BS; Paul ME; Abramson SL; Ritz J; Shearer WT
    J Allergy Clin Immunol; 2008 Dec; 122(6):1185-93. PubMed ID: 19084111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE
    N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow 'boosts' following T cell-depleted haploidentical bone marrow transplantation.
    Kline RM; Stiehm ER; Cowan MJ
    Bone Marrow Transplant; 1996 Apr; 17(4):543-8. PubMed ID: 8722352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow transplantation for T-B- severe combined immunodeficiency disease in Athabascan-speaking native Americans.
    O'Marcaigh AS; DeSantes K; Hu D; Pabst H; Horn B; Li L; Cowan MJ
    Bone Marrow Transplant; 2001 Apr; 27(7):703-9. PubMed ID: 11360109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
    Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro T cell depletion using Campath 1M for mismatched BMT for severe combined immunodeficiency (SCID).
    Dickinson AM; Reid MM; Abinun M; Peak J; Brigham K; Dunn J; Cant AJ
    Bone Marrow Transplant; 1997 Feb; 19(4):323-9. PubMed ID: 9051241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Roberts JL; Markert ML; Peters W; Williams LW; Ward FE
    Semin Hematol; 1993 Oct; 30(4 Suppl 4):92-101; discussion 102-4. PubMed ID: 7905667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J
    Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of tolerance after haplocompatible T-depleted bone marrow transplantation.
    Merino A; Dror Y; Benkerrou M; Colombe BW; Cowan MJ
    Bone Marrow Transplant; 1993 Nov; 12(5):483-8. PubMed ID: 8298559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation.
    Chiang KY; Hazlett LJ; Godder KT; Abhyankar SH; Christiansen NP; van Rhee F; Lee CG; Bridges K; Parrish RS; Henslee-Downey PJ
    Bone Marrow Transplant; 2001 Dec; 28(12):1117-23. PubMed ID: 11803352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.
    Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD
    Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploidentical peripheral blood stem cell transplantation with a combination of CD34 selection and T cell depletion as graft-versus-host disease prophylaxis in a patient with severe combined immunodeficiency.
    Martín-Hernández MP; Arrieta R; Martínez A; García P; Jimenez-Yuste V; Hernandez-Navarro F
    Bone Marrow Transplant; 1997 Nov; 20(9):797-9. PubMed ID: 9384486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
    Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
    Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matched unrelated bone marrow transplantation for combined immunodeficiency.
    Dalal I; Reid B; Doyle J; Freedman M; Calderwood S; Saunders F; Roifman CM
    Bone Marrow Transplant; 2000 Mar; 25(6):613-21. PubMed ID: 10734295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency.
    Lanfranchi A; Verardi R; Tettoni K; Neva A; Mazzolari E; Pennacchio M; Pasic S; Ugazio AG; Albertini A; Porta F
    Haematologica; 2000 Nov; 85(11 Suppl):41-6. PubMed ID: 11268323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of in vivo lymphocyte-depleting strategies on development of lymphoproliferative disorders in children post allogeneic bone marrow transplantation.
    Lynch BA; Vasef MA; Comito M; Gilman AL; Lee N; Ritchie J; Rumelhart S; Holida M; Goldman F
    Bone Marrow Transplant; 2003 Sep; 32(5):527-33. PubMed ID: 12942101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polysaccharide antibody responses are impaired post bone marrow transplantation for severe combined immunodeficiency, but not other primary immunodeficiencies.
    Slatter MA; Bhattacharya A; Flood TJ; Spickett GP; Cant AJ; Abinun M; Gennery AR
    Bone Marrow Transplant; 2003 Jul; 32(2):225-9. PubMed ID: 12838289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].
    Cavazzana-Calvo M; André-Schmutz I; Hacein-Bey S; Schindler J; Vitetta H; Dupuis S; Quartier P; Chedeville G; Vilmer E; Casanova JL; Buffet R; Caillat-Zucman S; Radford I; Le Deist F; Fischer A
    J Soc Biol; 2001; 195(1):65-8. PubMed ID: 11530503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique.
    Meijer E; Slaper-Cortenbach IC; Thijsen SF; Dekker AW; Verdonck LF
    Bone Marrow Transplant; 2002 Feb; 29(4):335-9. PubMed ID: 11896431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.